The Recall Desk

Manufacturer

Nephron Pharmaceuticals Corp.

10 recalls in our database name Nephron Pharmaceuticals Corp. as the manufacturing or recalling firm.

What the numbers show

Total
10
Critical
0
Severe
3
Most recent
2016-07-06

Of the 10 recalls from Nephron Pharmaceuticals Corp. we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 3 (30%) are Severe.

Which agencies issued them

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–10 of 10

  • HighFDA (Devices)·Z-2053-2016·2016-07-06

    Nephron Recalls Sodium Chloride Inhalation Solution Due to Sterility Concerns

    Nephron Pharmaceuticals is recalling 11,208 cartons of Sodium Chloride Inhalation Solution because internal dye tests failed to confirm vial integrity.

    Product
    Sodium Chloride Inhalation Solution, USP 3%, 60 x 4 mL Sterile Unit-Dose Vials per carton, Rx Only, NDC 0487-9003-60. A vial contains sterile, preservation-free, clear, colorless, aqueous solution as labeled for induction of sputum production where specimen collection is indica
    Category
    Medical Device
    Distribution
    36 states
  • HighFDA (Devices)·Z-2054-2016·2016-07-06

    Nephron Recalls Sodium Chloride Inhalation Solution Due to Sterility Concerns

    Nephron Pharmaceuticals is recalling 13,692 cartons of Sodium Chloride Inhalation Solution due to a failure in the internal dye ingress test, which raises concerns about the sterility of the vials.

    Product
    Sodium Chloride Inhalation Solution, USP 7%, 60 x 4 mL Sterile Unit-Dose Vials, Rx Only, NDC 0487-9007-60. A vial contains sterile, preservation-free, clear, colorless, aqueous solution as labeled for induction of sputum production where specimen collection is indicated. For res
    Category
    Medical Device
    Distribution
    36 states
  • ModerateFDA (Drugs)·D-0388-2016·2015-12-09

    Nephron Recalls Asthmanefrin Inhalation Solution Due to Discoloration

    Nephron Pharmaceuticals is voluntarily recalling Asthmanefrin inhalation solution starter kits due to discoloration. The recall covers 47,754 cartons distributed nationwide.

    Product
    Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator, Starter Kit (Racepinephrine 11.25 mg) 10 individual foil wrapped vials with 1 EZ Breathe Atomizer per carton, Manufactured By: nephron pharmaceuticals corporation, Orlando, FL --- NDC 0487-2784-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0389-2016·2015-12-09

    Nephron Recalls Asthmanefrin Racepinephrine Inhalation Solution Due to Discoloration

    Nephron Pharmaceuticals is recalling 32,490 cartons of Asthmanefrin Racepinephrine Inhalation Solution due to discoloration. The FDA classifies this as a Class II recall.

    Product
    Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator Refills (Racepinephrine USP 11.25 mg), 30 individual foil wrapped vials per carton, Manufactured By: nephron pharmaceuticals corporation, Orlando, FL --- NDC 0487-2784-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0010-2016·2015-10-21

    Nephron Recalls Ipratropium Bromide and Albuterol Sulfate Inhalation Solution

    Nephron Pharmaceuticals is recalling Ipratropium Bromide and Albuterol Sulfate inhalation solution due to a lack of assurance of sterility.

    Product
    IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE — IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE (IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-1373-2013·2013-06-05

    Nephron Pharmaceuticals Recalls EZ Breathe Medication Cups Due to Choking Hazard

    Nephron Pharmaceuticals is recalling EZ Breathe Medication Cups because a component may dislodge, creating a potential choking hazard.

    Product
    EZ Breathe Medication Cup. For the delivery of liquid medications for respiratory usage.
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-1371-2013·2013-06-05

    FDA Recalls EZ Breathe Atomizers Due to Choking Hazard

    Nephron Pharmaceuticals is recalling EZ Breathe Atomizers because a component may dislodge, creating a choking hazard.

    Product
    EZ Breathe Atomizer Model # EZ-100. For the delivery of liquid medications for respiratory usage.
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • HighFDA (Devices)·Z-1372-2013·2013-06-05

    AsthmaNefrin Starter Kit Recalled for Choking Hazard

    Nephron Pharmaceuticals is recalling AsthmaNefrin Starter Kits because a component may dislodge and cause a choking hazard.

    Product
    AsthmaNefrin Starter Kit contains ten (10) AsthmaNefrin vials and one (1) EZ Breathe Atomizer. For the delivery of liquid medications for respiratory usage.
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1446-2012·2012-08-15

    Nephron Recalls Albuterol Sulfate Inhalation Solution Due to Sterility Concerns

    Nephron Pharmaceuticals is recalling Albuterol Sulfate Inhalation Solution because the company cannot ensure the product is sterile. The recall affects 56,028 cartons distributed nationwide and in Puerto Rico.

    Product
    ALBUTEROL SULFATE — ALBUTEROL SULFATE (ALBUTEROL SULFATE)
    Category
    Drug
    Distribution
    Distributed nationwide